Apoptosis, proliferation, Bax, Bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer
- 1 June 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 41 (3) , 585-591
- https://doi.org/10.1016/s0360-3016(98)00076-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chronic irradiation enteritis: Its correlation with the elapsed time interval and morphological changesHuman Pathology, 1996
- Association of p53 Gene and Protein Alterations with Metastases in Colorectal CancerThe American Journal of Surgical Pathology, 1995
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- Apoptosis and a re-investigation of the biologic basis for cancer therapyRadiotherapy and Oncology, 1994
- p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 1994
- p53: a Glimpse at the Puppet Behind the Shadow PlayScience, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological statesThe Journal of Pathology, 1993
- Mechanisms and Functions of Cell DeathAnnual Review of Cell Biology, 1991
- p53 Mutations in Human CancersScience, 1991